Spyre Therapeutics, Inc.
SYRENASDAQNASDAQ Capital Market·USD·Closed
$31.98
−$1.60 (4.76%)
$31.98
−$1.60 (4.76%)
Not investment advice.Learn more
52W Range
Near 52-week high
Volume
Market Cap
Small-cap company
P/E Ratio
Div Yield
No dividend
SYRE has more going for it than against it right now.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required